|
Volumn 24, Issue 3, 2018, Pages 254-255
|
The intestinal microbiome influences checkpoint blockade
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTIBODY;
CYCLOPHOSPHAMIDE;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY;
PLATINUM;
PROGRAMMED DEATH 1 LIGAND 1;
PROGRAMMED DEATH 1 LIGAND 1 ANTIBODY;
TUMOR ANTIGEN;
UNCLASSIFIED DRUG;
ACTINOBACTERIA;
ARTICLE;
BACTEROIDES;
BACTEROIDETES;
BIFIDOBACTERIUM;
CANCER IMMUNOTHERAPY;
CD4+ T LYMPHOCYTE;
CD8+ T LYMPHOCYTE;
CELL CYCLE CHECKPOINT;
COLON FLORA;
CYTOTOXIC T LYMPHOCYTE;
DRUG RESPONSE;
ENTEROCOCCUS;
FECAL MICROBIOTA TRANSPLANTATION;
FIRMICUTES;
HUMAN;
IMMUNE RESPONSE;
INTESTINE FLORA;
METASTATIC MELANOMA;
MISMATCH REPAIR;
NON SMALL CELL LUNG CANCER;
NONHUMAN;
PRIORITY JOURNAL;
PROTEOBACTERIA;
REGULATORY T LYMPHOCYTE;
RENAL CELL CARCINOMA;
RUMINOCOCCUS;
TH1 CELL;
TH17 CELL;
TREATMENT OUTCOME;
TUMOR IMMUNITY;
TUMOR MICROENVIRONMENT;
VERRUCOMICROBIA;
ANIMAL;
BACTERIUM;
BIODIVERSITY;
FECES;
IMMUNE SYSTEM;
IMMUNOTHERAPY;
METABOLISM;
MICROBIOLOGY;
MOUSE;
ANIMALS;
BACTERIA;
BIODIVERSITY;
FECES;
GASTROINTESTINAL MICROBIOME;
HUMANS;
IMMUNE SYSTEM;
IMMUNOTHERAPY;
MICE;
|
EID: 85043263545
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm.4511 Document Type: Article |
Times cited : (38)
|
References (11)
|